Laurion Capital Management LP 10x Genomics, Inc. Transaction History

Laurion Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $313,890 - $700,072	-8,495 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $350,910 - $918,477	-6,300 Reduced 42.58%	8,495 $646,000
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $850,815 - $1.15 Million	6,300 Added 74.16%	14,795 $2.2 Million
Q2 2021 Aug 13, 2021	BUY	$134.22 - $202.37 $1.14 Million - $1.72 Million	8,495 New	8,495 $1.66 Million
Q1 2021 May 14, 2021	SELL	$140.25 - $196.86 $4.77 Million - $6.7 Million	-34,042 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$126.47 - $163.7 $3.04 Million - $3.94 Million	24,042 Added 240.42%	34,042 $4.82 Million
Q3 2020 Nov 13, 2020	BUY	$87.44 - $125.0 $874,400 - $1.25 Million	10,000 New	10,000 $1.25 Million
Q4 2019 Feb 13, 2020	SELL	$46.07 - $79.54 $691,050 - $1.19 Million	-15,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$49.99 - $62.0 $749,850 - $930,000	15,000 New	15,000 $756,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.